7:06 AM
May 16, 2017
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Breast cancer

Cell culture studies suggest that artificial vesicles loaded with Zybrestat fosbretabulin and doxorubicin could help treat doxorubicin-resistant breast cancer. The artificial vesicles consisted of amphiphilic block co-polymers loaded with Zybrestat fosbretabulin and doxorubicin. In a doxorubicin-resistant human...

Read the full 179 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >